我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
4
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
招募中
1
25.0%
Unknown
撤回
2
50.0%
暂无批准数据
- Researchers at the University of Illinois Hospital & Clinics validated the Sybil AI model's accuracy in predicting lung cancer risk within a predominantly Black patient population, addressing critical racial disparities in screening. - The deep learning model achieved an Area Under the Curve of 0.94 for one-year cancer risk prediction, demonstrating remarkable accuracy in a cohort where 62% of participants identified as Non-Hispanic Black. - The study analyzed 2,092 baseline low-dose CT screenings over a decade, with 68 patients subsequently diagnosed with lung cancer during follow-up periods extending up to 10.2 years. - The Sybil Implementation Consortium plans to initiate prospective clinical trials to integrate the AI tool directly into clinical workflows for real-world lung cancer screening programs.